Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$25.3 n/a | n/a%
02/24/17 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 147.47M 92.68M 12.02M 1.48M
Cost of Sales 6.75M 2.74M 1.10M 0.00
Gross Operating Profit 140.71M 89.94M 10.91M 1.48M
Selling, General, and Administrative Expenses 89.06M 72.61M 55.59M 20.13M
Research & Development 29.14M 19.59M 17.25M 23.52M
Operating Income before D & A (EBITDA) 22.51M -2.26M -61.92M -42.17M
Depreciation & Amortization 1.67M 3.02M 3.77M 1.20M
Interest Income 643.00K 348.00K 299.00K 120.00K
Other Income - Net -2.11M 256.00K -22.80M -660.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 19.38M -4.67M -88.20M -43.91M
Interest Expense 4.77M 5.62M 7.85M 3.58M
Pre-Tax Income 14.61M -10.29M -96.05M -47.48M
Income Taxes 666.00K 630.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 13.94M -10.93M -92.27M -46.28M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 13.94M -10.93M -92.27M -46.28M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 13.94M -10.93M -92.27M -46.28M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
13.94M -10.93M -92.27M -46.28M
Preferred Dividends
Net Income Available To Common 13.94M -10.93M -92.27M -47.43M
Basic EPS from Continuing Ops. 0.29 -0.26 -2.90 -2.72
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.29 -0.26 -2.90 -2.72
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.29 -0.26 -2.90 -2.72
Basic Normalized Net Income/Share 0.29 -0.26 -2.90 -2.72
EPS fr Continuing Ops. 0.28 -0.26 -2.90 -2.72
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.28 -0.26 -2.90 -2.72
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.28 -0.26 -2.90 -2.72
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.28 -0.26 -2.90 -2.72
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases

Partner Headlines for SUPN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter